×
GN Store Nord Total Long Term Liabilities 2016-2024 | GNNDY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
GN Store Nord total long term liabilities from 2016 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
View More
GN Store Nord Total Long Term Liabilities 2016-2024 | GNNDY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
GN Store Nord total long term liabilities from 2016 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$204.2B
Stryker (SYK)
$146.7B
Boston Scientific (BSX)
$132.6B
EssilorLuxottica (ESLOY)
$112.1B
Medtronic (MDT)
$110.6B
Haleon (HLN)
$43.7B
Lonza Group Ag (LZAGY)
$42.2B
GE HealthCare Technologies (GEHC)
$37.7B
ResMed (RMD)
$35.8B
Terumo (TRUMY)
$29.7B
Koninklijke Philips (PHG)
$24.8B
Zimmer Biomet Holdings (ZBH)
$21.9B
Insulet (PODD)
$18.4B
Baxter (BAX)
$17B
Smith & Nephew SNATS (SNN)
$11.1B
BellRing Brands (BRBR)
$10.2B
Bio-Rad Laboratories (BIO)
$9.3B
Demant (WILYY)
$8.3B
Lantheus Holdings (LNTH)
$6.3B
TG Therapeutics (TGTX)
$5.5B
Haemonetics (HAE)
$4.3B
Prestige Consumer Healthcare (PBH)
$4.2B
ICU Medical (ICUI)
$4.1B
Perrigo (PRGO)
$3.8B
Envista Holdings (NVST)
$3.7B
Neogen (NEOG)
$3.2B
Agios Pharmaceuticals (AGIO)
$3.2B
Shandong Weigao Medical Polymer (SHWGF)
$3B
QuidelOrtho (QDEL)
$2.7B
LeMaitre Vascular (LMAT)
$2.4B